192 filings
20-F
2023 FY
CMMB
Chemomab Therapeutics Ltd
Annual report (foreign)
28 Mar 24
6:03am
6-K
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
EFFECT
CMMB
Chemomab Therapeutics Ltd
6 Nov 23
Notice of effectiveness
12:15am
CORRESP
a8187hwkp49s9
1 Nov 23
Correspondence with SEC
12:00am
F-3/A
gzxjfck1akq9f dysu
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
9lwn4fhh
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
wtgkdixi
14 Aug 23
Current report (foreign)
8:05am
6-K
81ws6 jhdc
8 Aug 23
Current report (foreign)
6:00am
6-K
cqcz7scfx3gsmfoflv
3 Jul 23
Current report (foreign)
3:49pm
8-K
kf535uh7abxr5h
16 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
3k28qsms1
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
RW
wo8 kl3gn
2 Jun 23
Registration withdrawal request
4:02pm
8-K
j6dr9k389z2jk 8ty
11 May 23
Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
6:10am
ARS
phrab2
21 Mar 23
Annual report to shareholders
6:02am